Working to uncover the unknown about COVID-19

As the pharmaceutical industry continues to learn about COVID-19, IQVIA has called upon its experience with patient registries and analytics to create a direct-to-patient registry. The CARE Registry aims to

• Track symptom presentation, severity, and the progression of COVID-19 in the general population
• Monitor the treatments patients are using for COVID-19, as well as for other pre-existing conditions
• Provide reference or context for product safety studies
• Link CARE project data to other real world data sources to provide richer findings and insights